BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29789215)

  • 1. Clinical outcomes and influencing factors of in-stent restenosis after stenting for symptomatic stenosis of the vertebral V1 segment.
    Che WQ; Dong H; Jiang XJ; Peng M; Zou YB; Xiong HL; Yang YJ; Gao RL
    J Vasc Surg; 2018 Nov; 68(5):1406-1413. PubMed ID: 29789215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis.
    Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J
    J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Predictors of the In-stent Restenosis after Vertebral Artery Ostium Stenting.
    Chen W; Huang F; Li M; Jiang Y; He J; Li H; Dai Z; Shi W; Zhu M; Chen G; Yang F; Zhang R
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3030-3035. PubMed ID: 30093203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial occlusions increase the risk of in-stent restenosis after vertebral artery ostium stenting.
    Li J; Hua Y; Needleman L; Forsberg F; Eisenbray JR; Li Z; Liu R; Tian X; Jiao L; Liu JB
    J Neurointerv Surg; 2019 Jun; 11(6):574-578. PubMed ID: 30337379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results.
    Chen X; Huang Q; Hong B; Zhang Y; Xu Y; Liu J
    J Clin Neurosci; 2011 Jan; 18(1):47-51. PubMed ID: 20888236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting.
    Li MKA; Tsang ACO; Tsang FCP; Ho WS; Lee R; Leung GKK; Lui WM
    Clin Neuroradiol; 2019 Dec; 29(4):701-706. PubMed ID: 30039353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents.
    Li Z; Zhang Y; Hong B; Deng B; Xu Y; Zhao W; Liu J; Huang Q
    J Clin Neurosci; 2014 Feb; 21(2):274-7. PubMed ID: 24128770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies.
    Langwieser N; Buyer D; Schuster T; Haller B; Laugwitz KL; Ibrahim T
    J Endovasc Ther; 2014 Oct; 21(5):683-92. PubMed ID: 25290797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Respiratory Tortuosity of the Vertebral Artery Ostium.
    Tang X; Tang F; Hu C; Wang Q; Long W; Li L
    J Endovasc Ther; 2017 Feb; 24(1):124-129. PubMed ID: 27831484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and comparison of drug eluting stent to bare metal stent for restenosis rates following vertebral artery ostium stenting: A single-center real-world study.
    Li L; Wang X; Yang B; Wang Y; Gao P; Chen Y; Zhu F; Ma Y; Chi H; Zhang X; Bai X; Feng Y; Dmytriw AA; Hong T; Hua Y; Jiao L; Ling F
    Interv Neuroradiol; 2020 Oct; 26(5):629-636. PubMed ID: 32799746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Compter A; van der Worp HB; Schonewille WJ; Vos JA; Boiten J; Nederkoorn PJ; Uyttenboogaart M; Lo RT; Algra A; Kappelle LJ;
    Lancet Neurol; 2015 Jun; 14(6):606-14. PubMed ID: 25908089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stenting of the first segment of the spinal artery in the acutest period of ischemic stroke in the vertebrobasilar territory].
    Kazantsev AN; Vinogradov RA; Kravchuk VN; Chernyavskiy MA; Shabaev AR; Kachesov EY; Bagdavadze GS; Vayman EF; Porkhanov VA; Khubulava GG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):38-45. PubMed ID: 33908231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series.
    Akins PT; Kerber CW; Pakbaz RS
    J Invasive Cardiol; 2008 Jan; 20(1):14-20. PubMed ID: 18174613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Experience of Surgical Explantation of Carotid Stents for Recurrent Stenosis.
    Columbo JA; McCallum JC; Goodney PP; Bower TC; Schermerhorn ML; Powell RJ; DeMartino RR
    Vasc Endovascular Surg; 2016 Nov; 50(8):547-553. PubMed ID: 27881699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Different Endovascular Treatment for Vertebral Artery Origin Stenosis.
    Wang Z; Ling Y; Zhao H; Mao Y; Dong Q; Cao W
    World Neurosurg; 2022 Aug; 164():e1290-e1297. PubMed ID: 35700860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium.
    Zhou Z; Yin Q; Xu G; Yue X; Zhang R; Zhu W; Fan X; Ma M; Liu X
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):481-7. PubMed ID: 20683721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting.
    Wang ZL; Gao BL; Li TX; Cai DY; Zhu LF; Bai WX; Xue JY; Li ZS
    Eur J Radiol; 2015 Sep; 84(9):1801-4. PubMed ID: 26119803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for in-stent restenosis after vertebral artery stenting of V1 segment: A systematic review and meta-analysis.
    Guo J; Ning Y; Wu S; Zhang F; Li Y; Xu Z; Guo L; Gu Y
    Catheter Cardiovasc Interv; 2022 Aug; 100(2):279-289. PubMed ID: 35730645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.
    Gandini R; Del Giudice C; Da Ros V; Sallustio F; Altobelli S; D'Onofrio A; Abrignani S; Vasili E; Stanzione P; Simonetti G
    J Endovasc Ther; 2014 Oct; 21(5):671-7. PubMed ID: 25290795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.